Related Experiment Video
Updated: Aug 25, 2025
Author Spotlight: Minimally Invasive Ultrasound-Guided Acupotomy in Knee Osteoarthritis Treatment
Published on: April 26, 2024
Efficacy of an Intra-articular Ozone Injection for Chronic Knee Pain Due to Osteoarthritis
Context:
Osteoarthritis (OA) is the most common form of arthritis, affecting an estimated 302-million people worldwide, and it's a leading cause of disability among older adults. Current treatments for OA are largely unsatisfactory. Ozone is an inexpensive, accessible, and easily applicable treatment for OA.
Objective:
The study aimed to retrospectively evaluate the effects of a short-term, three-month OA treatment using an intra-articular ozone injection, on pain and physical function in patients with stage 2-3 knee OA.
Design:
The research team designed the study as a retrospective review of files from a hospital's archive as well as the results of a follow-up questionnaire about pain that patients completed at a related clinic.
Setting:
The study took place at the Algology Clinic at Ankara University in Ankara, Turkey.
Participants:
Participants were 94 patients, aged between 28 and 75 years, with stage 2-3 OA who had applied to the clinic between January 1, 2018 and January 1, 2020 and had received an intra-articular ozone injection.
Intervention:
Participants received intra-articular ozone treatments at a dose of 10 ml at 15 mcg/ml for 4 weeks, once a week.
Outcome Measures:
Participants completed a visual analogue score (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), measuring pain at baseline and at one month and at 3 months postintervention. The study also determined if the treatment had an effect on analgesic drug use and measured patient satisfaction.
Results:
The decreases in participants' pain scores on both scales were statistically significant at one month and at 3 months postintervention (P = .000). The need for analgesic medication had decreased for 56 participants (61.5%) at one month postintervention and for 50 (54.9%) at 3 months postintervention. Of the 94 participants, 66 (70.2%) were satisfied and 28 (29.8) weren't.
Conclusions:
The intra-articular injection of ozone, applied once a week for 4 weeks, resulted in a reduction in pain in stage 2-3 knee OA, without any side effects. However, further studies are needed to resolve the uncertainties in dosage, number of sessions, and intervals for intra-articular ozone injections. The current study's results need support from further prospective studies that can evaluate the efficacy of ozone treatment for a longer period of time.
